Margaret Pax
Fortuna: 544 931 $ al 31/08/2026
Fortuna: 544 931 $ al 31/08/2026
Ms. Margaret A. Pax is an Independent Director at Repligen Corp.
and an Independent Director at Jellagen Pty Ltd. She is on the Board of Directors at Repligen Corp., BioPorto, Inc., Harvard Business School Health Industry Alumni Association and Jellagen Pty Ltd. Ms. Pax was previously employed as an Independent Director by Alimera Sciences, Inc., a Vice President-Business Development by Microchips Biotech, Inc., and a Vice President-Marketing by OmniSonics Medical Technologies, Inc. She also served on the board at Bioporto A/S.
She received her undergraduate degree from the College of the Holy Cross (Massachusetts) and an MBA from Harvard Business School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
REPLIGEN CORPORATION 0,01 % | 14/05/2026 | 3.011 ( 0,01 % ) | 544 931 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| REPLIGEN CORPORATION | Director/Miembro de la Junta | 18/03/2024 |
Bioporto, Inc. | Director/Miembro de la Junta | - |
Jellagen Pty Ltd.
Jellagen Pty Ltd. Food: Meat/Fish/DairyConsumer Non-Durables Produces research grade functional non-mammalian collagen products | Director/Miembro de la Junta | - |
Harvard Business School Health Industry Alumni Association | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| ALIMERA SCIENCES, INC. | Director/Miembro de la Junta | 16/09/2024 |
| BIOPORTO A/S | Director/Miembro de la Junta | - |
OmniSonics Medical Technologies, Inc.
OmniSonics Medical Technologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Ventas & Marketing | - |
Microchips Biotech, Inc.
Microchips Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops drug delivery systems and biosensing devices | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Repligen Corp.
Repligen Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures biologic drugs | Health Technology |
Alimera Sciences, Inc.
Alimera Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops, manufactures and commercializes therapeutics for ophthalmology, rheumatology, nephrology, neurology & pulmonology problems | Health Technology |
OmniSonics Medical Technologies, Inc.
OmniSonics Medical Technologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Bioporto A/S
Bioporto A/S Medical SpecialtiesHealth Technology Develops and markets human and animal neutrophil gelatinase-associated lipocalin antibodies kits | Health Technology |
College of the Holy Cross (Massachusetts)
College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Microchips Biotech, Inc.
Microchips Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops drug delivery systems and biosensing devices | Health Technology |
Harvard Business School Health Industry Alumni Association | |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jellagen Pty Ltd.
Jellagen Pty Ltd. Food: Meat/Fish/DairyConsumer Non-Durables Produces research grade functional non-mammalian collagen products | Consumer Non-Durables |
Bioporto, Inc. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.